pentobarbital will reduce the level or result of aripiprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will lessen the extent or impact of dapsone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.

pentobarbital will reduce the extent or impact of fosaprepitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will minimize the level or influence of losartan by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Not known.

pentobarbital will reduce the level or outcome of ripretinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will reduce the extent or outcome of tipranavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

CYP3A4 inducers may well raise the formation of your neurotoxic/nephrotoxic ifosfamide metabolite, chloroacetaldehyde. Closely keep track of clients having ifosfamide with CYP3A4 inducers for toxicities and consider dose adjustment.

Keep an eye on Closely (one)pentobarbital will reduce the extent or impact of cannabidiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will reduce the level or impact of sunitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

With therapeutic doses of TCAs, barbiturates maximize metabolism and reduce blood concentrations of TCAs.

pentobarbital will lower the level or effect of cinacalcet by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

pentobarbital will decrease the extent or impact of atorvastatin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital check here will lessen the level or influence of propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.

fentanyl iontophoretic transdermal system and pentobarbital each improve sedation. Steer clear of or Use Alternate Drug. Limit use to people for whom alternate procedure solutions are insufficient